Biodesix Receives $5,121,632 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=82c2b9ab-3fd0-421f-b0f4-c8b732cefbf4 - Date
12/1/2016 - Company Name
Biodesix - Mailing Address
2970 Wilderness Place Boulder, CO 80301 USA - Company Description
Biodesix makes blood-based diagnostic tests that help guide treatment of patients with advanced cancer. Our test results are available within 72 hours. - Website
http://www.biodesix.com - Transaction Type
Venture Equity - Transaction Amount
$5,121,632 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 12 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
